BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 11787127)

  • 1. [Juvenile rheumatoid arthritis].
    Honkanen V; Lahdenne P
    Duodecim; 2000; 116(8):839-43. PubMed ID: 11787127
    [No Abstract]   [Full Text] [Related]  

  • 2. What's new in the diagnosis and treatment of juvenile rheumatoid arthritis.
    Sherry DD
    J Pediatr Orthop; 2000; 20(4):419-20. PubMed ID: 10912594
    [No Abstract]   [Full Text] [Related]  

  • 3. [TNF-alpha inhibitors].
    Fain O
    Rev Prat; 2003 Nov; 53(18):1989-90. PubMed ID: 15008210
    [No Abstract]   [Full Text] [Related]  

  • 4. Tumor necrosis factor blockers in rheumatoid arthritis.
    Pisetsky DS
    N Engl J Med; 2000 Mar; 342(11):810-1. PubMed ID: 10717018
    [No Abstract]   [Full Text] [Related]  

  • 5. [Recommendations for the appropriate use of anti-TNFalpha therapy in patients with psoriatic arthritis. Italian Rheumatology Society].
    Salvarani C; Olivieri I; Cantini F; Marchesoni A; Punzi L; Scarpa R; Matucci-Cerinic M
    Reumatismo; 2004; 56(3):133-4, 136-8. PubMed ID: 15470517
    [No Abstract]   [Full Text] [Related]  

  • 6. [So that the patients.would be able to move for a long time after first diagnosis of rheumatism. Approach as an emergency!].
    Fath R
    MMW Fortschr Med; 2004 Sep; 146(37):4-5. PubMed ID: 15887690
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of juvenile idiopathic arthritis].
    Yokota S; Umebayashi H; Katakura S; Imagawa T; Mori M
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():453-8. PubMed ID: 15799398
    [No Abstract]   [Full Text] [Related]  

  • 8. Methotrexate: more questions than answers.
    Wallace CA
    J Rheumatol; 2000 Aug; 27(8):1834-5. PubMed ID: 10955320
    [No Abstract]   [Full Text] [Related]  

  • 9. New treatments for juvenile idiopathic arthritis.
    Hashkes PJ; Friedland O; Uziel Y
    Isr Med Assoc J; 2002 Jan; 4(1):39-43. PubMed ID: 11802310
    [No Abstract]   [Full Text] [Related]  

  • 10. Methotrexate in juvenile idiopathic arthritis: answers and questions.
    Ravelli A; Martini A
    J Rheumatol; 2000 Aug; 27(8):1830-3. PubMed ID: 10955319
    [No Abstract]   [Full Text] [Related]  

  • 11. [Combination drug therapy in rheumatoid arthritis].
    Kawai S
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():549-55. PubMed ID: 15799416
    [No Abstract]   [Full Text] [Related]  

  • 12. Emerging therapies in juvenile rheumatoid/idiopathic arthritis.
    Passo M
    Curr Probl Pediatr Adolesc Health Care; 2006 Mar; 36(3):97-103. PubMed ID: 16473286
    [No Abstract]   [Full Text] [Related]  

  • 13. [Anti-TNF-alpha treatment and spondyloarthropathies].
    Braun Y; Balbir-Gurman A
    Harefuah; 2002 Nov; 141(11):965-8, 1010. PubMed ID: 12476631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact on health-related quality of life from non-steroidal anti-inflammatory drugs, methotrexate, or steroids in treatment for juvenile idiopathic arthritis.
    Riddle R; Ryser CN; Morton AA; Sampson JD; Browne RH; Punaro MG; Gatchel RJ
    J Pediatr Psychol; 2006 Apr; 31(3):262-71. PubMed ID: 15872147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Taiwan experience with etanercept in juvenile rheumatoid arthritis.
    Lai JH
    J Microbiol Immunol Infect; 2005 Dec; 38(6):451-4. PubMed ID: 16341348
    [No Abstract]   [Full Text] [Related]  

  • 16. Etanercept (Enbrel) -- an update.
    Goffe B
    Skin Therapy Lett; 2004 Dec-2005 Jan; 9(10):1-4, 9. PubMed ID: 15657632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Juvenile Still's disease: a case report of treatment with infliximab].
    Meddeb N; Rammeh N; Gandoura N; Elleuch M; Cheour E; Sahli H; Hamza S; Maalej A; Sellami S
    Therapie; 2002; 57(4):407-8. PubMed ID: 12422562
    [No Abstract]   [Full Text] [Related]  

  • 18. Juvenile idiopathic arthritis: current and future treatment options.
    Martini G; Zulian F
    Expert Opin Pharmacother; 2006 Mar; 7(4):387-99. PubMed ID: 16503811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-tumor necrosis factor alpha switching in rheumatoid arthritis and juvenile chronic arthritis.
    Favalli EG; Arreghini M; Arnoldi C; Panni B; Marchesoni A; Tosi S; Pontikaki I
    Arthritis Rheum; 2004 Apr; 51(2):301-2. PubMed ID: 15077278
    [No Abstract]   [Full Text] [Related]  

  • 20. Should anti-tumor necrosis factor-alpha be the first therapy for rheumatoid vasculitis?
    Garcia-Porrua C; Gonzalez-Gay MA; Quevedo V
    J Rheumatol; 2006 Feb; 33(2):433; author reply 433-4. PubMed ID: 16465676
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.